[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351346-105":59,"doc-detail-351346-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biobanking-of-gynecologic-cancer-biospecimens-development-quality-control-and-translational-applications","Biobanking of gynecologic cancer biospecimens: Development, quality control, and translational applications","","Nationwide biobanking infrastructure for gynecologic cancer biospecimens was established through the Korea Biobank Project to enable systematic collection and reuse. The work details a comprehensive biobanking strategy with standardized pre-analytical documentation, 2D barcode tracking, and rigorous quality-control practices. Secondary resources were generated to broaden translational research, including whole-genome sequencing datasets and multiple model systems such as immortalized cells, patient-derived xenografts, tumor organoids, and tissue microarrays linked to clinical and epidemiological data.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biobanking-of-gynecologic-cancer-biospecimens-development-quality-control-and-translational-applications/351346/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biobanking-of-gynecologic-cancer-biospecimens-development-quality-control-and-translational-applications/351346.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What infrastructure was developed for gynecologic cancer biospecimen collection?","Question",{"text":112,"@type":113},"A nationwide gynecologic cancer biobank was established through the Korea Biobank Project using a multi-institutional consortium to collect and distribute biospecimens.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were biospecimens collected and tracked, and what standardization was used?",{"text":117,"@type":113},"Biospecimens including blood, tumor tissue, urine, and ascites were collected from patients, pre-analytical variables were recorded using SPREC, and all samples were tracked with 2D barcodes.",{"name":119,"@type":110,"acceptedAnswer":120},"What secondary resources were produced to support translational applications?",{"text":121,"@type":113},"The study generated secondary resources including whole-genome sequencing datasets, authenticated immortalized cell lines, patient-derived xenografts, patient-derived tumor organoids, and tissue microarrays.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351346,1790618290,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","OPEN ACCESS  \nCitation: Kim JY, Lee Y-K, Shin H-Y, Kim YJ, Jeon MA, Yang W, et al. (2026) Biobanking of gynecologic cancer biospecimens:  \nDevelopment, quality control, and translational applications. PLoS One 21(3): e0345861 .  \n[https://doi.org/10.1371/journal.pone.0345861](https://doi.org/10.1371/journal.pone.0345861)  \nEditor: Kazunori Nagasaka, Teikyo University, School of Medicine, JAPAN  \nReceived: September 23, 2025  \nAccepted: March 10, 2026  \nPublished: March 31, 2026  \nCopyright: © 2026 Kim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files. In addition, biospecimens and associated datasets are available to qualified researchers through the Korea Biobank Integrated System ([https://biobank.nih.go.kr](https://biobank.nih.go.kr)) upon approval of a research proposal and  \nRESEARCH ARTICLE  \nBiobanking of gynecologic cancer biospecimens: Development, quality control, and translational applications  \nJue Young Kim1☯, Yoo-Kyung Lee1☯, Ha-Yeon Shin1, Yoon Joo Kim1, Mi Ae Jeon1, Wookyeom Yang1,2, Anna Jun1, Kyungmin Kim1, Hanbyoul Cho1, Min-A Kim1, Jae-Hoon Kim1*  \n1 Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea, 2 Department of Anti-cancer evaluation team, R&D Institute, ORGANOIDSCIENCES Ltd. , Seongnam-si, Republic of Korea  \n☯ These authors contributed equally to this work and share first authorship.  \n* [jaehoonkim@yuhs.ac](jaehoonkim@yuhs.ac)  \nAbstract  \nIntroduction  \nThis study presents a nationwide infrastructure for the collection and utilization of gynecologic cancer biospecimens, established through the Korea Biobank Project. We comprehensively describe the biobanking strategy, quality control protocols, and development of secondary resources to support future translational and discoverybased research.  \nMethods  \nWe established a gynecologic cancer biobank within the Korea Biobank Project (KBP) through a multi-institutional consortium. Biospecimens, including blood, tumor tissue, urine, and ascites, were collected from 294 patients with endometrial, cervical, or ovarian cancers. Pre-analytical variables were documented using the Standard PREanalytical Code (SPREC), and all samples were tracked with 2D barcodes. Secondary resources were developed, including whole-genome sequencing (WGS) datasets, immortalized human ovarian surface epithelial (IHOSE) cell lines, patientderived xenografts (PDX), tumor organoids, and tissue microarrays (TMAs) .  \nResults  \nA total of 6,168 biospecimens were archived. WGS was performed on 386 cancer samples, including 172 paired tumor–normal sets. Four IHOSE cell lines were authenticated and validated for stability, 14 PDX models retained histological fidelity across passages, and patient-derived ovarian cancer organoids demonstrated drug sensitivity consistent with clinical response patterns. TMAs were constructed from  \nPLOS One | [https://doi.org/10.1371/journal.pone.0345861](https://doi.org/10.1371/journal.pone.0345861) March 31, 2026 1 / 19  \ncompletion of required data access agreements, in accordance with institutional and national regulations governing human biospecimens and associated datasets. These access procedures are required to protect participant privacy and comply with ethical and legal regulations.  \nFunding: This research was supported by the National Institute of Health, Republic of Korea (project No. 2024ER051701) . The funders were involved in the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.  \nCompeting interests: Wookyeom Yang is affiliated with ORGANOIDSCIENCES Ltd. , a for-profit company that participa","cbCaicGXAcwdQYrS","https://ap.wps.com/l/cbCaicGXAcwdQYrS","pdf",3023539,"English","# Abstract\n# Introduction\n# Methods\n## Biobank development and specimen collection\n## Secondary resources and quality control\n# Results\n## Archived biospecimens and WGS\n## Model systems and validation\n# Funding\n# Competing interests\n# Conclusions","[{\"question\":\"What infrastructure was developed for gynecologic cancer biospecimen collection?\",\"answer\":\"A nationwide gynecologic cancer biobank was established through the Korea Biobank Project using a multi-institutional consortium to collect and distribute biospecimens.\"},{\"question\":\"How were biospecimens collected and tracked, and what standardization was used?\",\"answer\":\"Biospecimens including blood, tumor tissue, urine, and ascites were collected from patients, pre-analytical variables were recorded using SPREC, and all samples were tracked with 2D barcodes.\"},{\"question\":\"What secondary resources were produced to support translational applications?\",\"answer\":\"The study generated secondary resources including whole-genome sequencing datasets, authenticated immortalized cell lines, patient-derived xenografts, patient-derived tumor organoids, and tissue microarrays.\"}]","Biobanking of gynecologic cancer biospecimens: Development, quality control, and translational applications | PDF",1790093640,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c7bc783413debc28d7d6795f4eb1251.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f81ab86f199076245ed7561922d31f9.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ea48821a55e0fe9122734c96a486c07.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c58a3c27dd15a7584479c4e5b9da51a.webp",980,1268]